First Eagle Investment Management’s NEOPHOTONICS CORP NPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-62,662
Closed -$953K 416
2022
Q1
$953K Buy
62,662
+17,162
+38% +$261K ﹤0.01% 294
2021
Q4
$699K Buy
+45,500
New +$599K ﹤0.01% 259

Other funds holding NPTN

First Eagle Investment Management's NPTN Position: Q2 2022 in Review

First Eagle Investment Management sold out of NEOPHOTONICS CORP (NPTN) in Q2 2022, closing a stake of 62,662 shares — an estimated $953K sold.

First Eagle Investment Management first reported a position in NPTN in Q4 2021 and held it in 2 quarters. The position peaked at $953K in Q1 2022. 156 funds tracked by Wall St. Rank hold NPTN as of Q2 2022.

  • First Eagle Investment Management reported no remaining NEOPHOTONICS CORP position as of Q2 2022 after selling out during the quarter.
  • First Eagle Investment Management sold 62,662 NEOPHOTONICS CORP shares in Q2 2022, an estimated $953K.
  • First Eagle Investment Management first reported a position in NEOPHOTONICS CORP in Q4 2021 and held it in 2 quarters.
  • First Eagle Investment Management's NEOPHOTONICS CORP position peaked at $953K in Q1 2022.
  • 156 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q2 2022.

Based on First Eagle Investment Management's 13F filing for Q2 2022, filed 10 Aug 2022.